VYCO logo

Vycor Medical, Inc. Stock Price

OTCPK:VYCO Community·US$5.0m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

VYCO Share Price Performance

US$0.15
0.07 (92.55%)
US$0.15
0.07 (92.55%)
Price US$0.15

VYCO Community Narratives

There are no narratives available yet.

Snowflake Analysis

Slight risk and slightly overvalued.

4 Risks
1 Reward

Vycor Medical, Inc. Key Details

US$1.8m

Revenue

US$253.6k

Cost of Revenue

US$1.5m

Gross Profit

US$1.9m

Other Expenses

-US$403.6k

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.012
85.75%
-22.69%
-24.2%
View Full Analysis

About VYCO

Founded
2005
Employees
7
CEO
Peter Zachariou
WebsiteView website
www.vycormedical.com

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement with a German-based partner. It primarily serves hospitals and medical professionals. The company was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

Recent VYCO News & Updates

Recent updates

No updates